Interpace Diagnostics Q3 Revenues Up 38 Percent
The company beat the consensus Wall Street estimate on the top line and guided to 2018 revenues of between $21 million and $22 million.
In Brief This Week: Akers Biosciences, Trinity Biotech, Rosetta Genomics, And More
Akers Biosciences reported this week that its first quarter revenues dropped 55 percent year over year, as lower yields in the process of extracting antigens for its flagship test product led to lower production levels and backorders.
Rosetta Genomics Files for Chapter 7 Bankruptcy
Rosetta had disclosed that it intended to file for bankruptcy after its merger with Genoptix was not completed as planned.
Rosetta Genomics Dispute With Genoptix Places Pending Merger in Jeopardy
The merger, which was previously scuttled and later revived with Rosetta shareholder approval, was due to close on May 27.
Feb 28, 2018
Rosetta Genomics, Genoptix Sign New Merger Agreement
Feb 23, 2018
Rosetta Genomics, Genoptix Merger Terminated
Dec 15, 2017
Genoptix to Acquire Rosetta Genomics for $10M
Sep 28, 2017
Rosetta Genomics Initiates $2M Private Placement
Sep 5, 2017
Rosetta Genomics Announces Layoffs
Mar 30, 2017